We make healthy possible by developing, manufacturing, and delivering more than 290 medicines, combining scale, precision, and care to expand access globally.
As we become stronger, more resilient, more of who we are, we are giving hope and new possibilities to patients. We are #BecomingAmneal. Learn more about how we make healthy possible at Amneal.com
In 2020, Amneal’s generic medicines were responsible for saving patients $9.8 billion* in the U.S. Increasing accessibility to key medicines is a core pillar of our work. Learn more about our Generics business and *savings calculation here: amneal.com/2022/04/amneal…
“Through this forum, we look forward to strengthening economic partnerships while also working together to resolve critical business challenges faced by the healthcare/pharmaceutical industry across both rapidly growing countries," -Chirag Patel, Co- Founder and Co-CEO.
The U.S. Food and Drug Administration (FDA) has accepted for review our Abbreviated New Drug Application (ANDA) for Naloxone Hydrochloride, USP, nasal spray, 4mg. This is the generic version of Narcan® and used in the treatment of a known or suspected opioid overdose emergency.
Today is a special day for patients, healthcare providers and our company. Amneal has officially entered the U.S. biosimilars market. Learn more: investors.amneal.com/news/press-rel…
Since 2020, 40 Amneal leaders have volunteered with @acpvets to mentor a veteran or active-duty spouse in the transition to civilian life. Amneal’s Alex Drigan is currently mentoring Bill, a senior-level strategist with 18+ years of military experience.
International commercial expansion is part of Amneal’s growth strategy. We’re excited to announce that Shyamakant Giri (@shyamgiri) has joined the Amneal family to lead our business development/partnership strategies for India, Southeast Asia, Middle East & Africa markets.
*As of August 4, 2023, Amneal has 3 reportable business segments: 1) Generics (includes retail, injectables, biosimilars & international revenue), 2) Specialty and 3) AvKARE (includes distribution, government label & institutional revenue).
Our business is evolving and so is our brand! We’ve refreshed Amneal.com to better reflect our expanded and innovation-driven business, leadership, confidence, authenticity, quality-first mindset and patient-focus.
Our dynamic team is readying one of our new, state-of-the-art injectables facilities. The facility adds in-house manufacturing and R&D and optimal real estate for future expansion. Learn more: amneal.com/products/our-p…
As part of a 100-day public awareness campaign focused on minimizing plastic use and promoting proper waste disposal, our India colleagues recently connected with students at local primary schools to discuss ways they can promote a healthy environment.
Amneal was founded in 2002 by brothers Chirag and Chintu Patel, who were inspired by their father, Kanu Patel, an industrial pharmacist who worked as a pharmaceutical regulatory inspector in India.